Tenderwize
Wróć do wyszukiwania

Non-exclusive discount agreement for Tamsulosin and Dutasterid

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Mar 31, 2027 · 217 days left·Open·Supplies
Structured notice only
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Tamsulosin und Dutasterid, ATC G04CA52

55/100

Ocena szansy

Needs reviewMedium complexity
SuppliesOpen
Skąd ta ocena?

Szansa

55 / 100

Złożoność

40 / 100

Czynniki ryzyka

Non-exclusive contracts may be terminated early if the buyer initiates exclusive tenders; no guaranteed revenue.

Paper submission increases risk of delays or loss; must meet strict receipt deadlines.

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Conclusion of non-exclusive discount agreements for pharmaceuticals with active substance Tamsulosin and Dutasterid (ATC G04CA52)
  • Exclusion of paediatric medicines according to BfArM list per §35 Abs. 5a SGB V
Pokaż pełne podsumowanie

The tender is an open-house non-exclusive discount agreement for pharmaceutical products containing Tamsulosin and Dutasterid (ATC G04CA52), offered by AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse. All eligible pharmaceutical companies can join on equal terms. Contracts run for a maximum of 24 months, with the earliest start on 01.06.2025 and latest end on 31.05.2027. Enrollment is possible monthly, subject to a two-month lead time. The notice explicitly states it is not a public procurement under EU directives but is published for transparency. No estimated value is provided.

Ryzyka

Non-exclusive contracts may be terminated early if the buyer initiates exclusive tenders; no guaranteed revenue.

Paper submission increases risk of delays or loss; must meet strict receipt deadlines.

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Pharmaceutical companies must hold a valid marketing authorization for the relevant products in Germany
  • Products must be listed as marketable in the Lauer-Taxe or provide evidence via AMIce database extracts

Administrative

  • Submission of signed contract documents by the appropriate deadline (first deadline 30.04.2025 for start 01.06.2025; subsequent deadlines are 2 months before intended start date)

Wymagania mogą być niepełne.

Kryteria udzielenia

Lot 1

No explicit award criteria; all participants are accepted under uniform terms (open-house).

Zamawiający

Lokalizacja

Eisenberg, DEU

Profil zamawiającego

Otwórz profil

Identyfikator

DE271900642

Działalność

Health

Części (1)

LOT-0001

Non-exclusive discount agreement for Tamsulosin and Dutasterid

Open-house model for non-exclusive discount agreements on pharmaceuticals with active substances Tamsulosin and Dutasterid. All qualified pharmaceutical companies can participate. Terms are uniform; no individual negotiations. Contracts end automatically if exclusive agreements replace them.

SuppliesEU fundedElectronic submission

Lokalizacja

Eisenberg, Germany

Czas trwania

May 2025 - May 2027

Kategoria

Pharmaceutical products

Kryteria udzielenia

No explicit award criteria; all participants are accepted under uniform terms (open-house).

Termin

Deadline Mar 31, 2027

Szczegóły zamówienia

Data publikacji
10 Apr 2025
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
236184-2025

Dokumenty (1)

Podobne przetargi